Financials

  • Market Capitalization 1.19 B
  • Employee 231
  • Founded 2005
  • CEO Linda Marban
  • Website www.capricor.com
  • Headquarter Delaware, United States
  • FIGI BBG000DZMK99
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-12.77
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2320
CRVS
Corvus Pharmaceuticals, Inc. - Common Stock
14.71 USD-6.13%-3.92%+22.48%+236.61%1.24 B USD
2348
EYPT
EyePoint, Inc. - Common Stock
14.28 USD-2.99%-2.53%+8.68%+19.00%1.20 B USD
2359
SVRA
Savara, Inc. - Common Stock
5.74 USD-4.81%-7.42%+6.89%+125.98%1.18 B USD
2379
WVE
Wave Life Sciences Ltd. - Ordinary Shares
5.95 USD-4.80%-7.18%+1.19%-16.90%1.14 B USD

Frequently asked questions about Capricor Therapeutics, Inc. - Common Stock

What is the Capricor Therapeutics, Inc. - Common Stock stock price today?

The current price of Capricor Therapeutics, Inc. - Common Stock (CAPR) is 20.61. Over the past 24 hours, the stock has changed by -4.18%. Follow the CAPR chart for real-time price dynamics.

What is the stock ticker of Capricor Therapeutics, Inc. - Common Stock?

Capricor Therapeutics, Inc. - Common Stock trades under the ticker CAPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Capricor Therapeutics, Inc. - Common Stock stock going up?

CAPR has changed by -8.56% over the last week, -20.85% over the last month, and +179.65% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Capricor Therapeutics, Inc. - Common Stock net income for the last quarter?

Capricor Therapeutics, Inc. - Common Stock reported net income of -33.94 M for the last quarter. The previous quarter showed -30.17 M, which means net income changed by -12.50%.

How many employees does Capricor Therapeutics, Inc. - Common Stock have?

As of the latest available data, Capricor Therapeutics, Inc. - Common Stock has 231 employees. Workforce size can provide additional context about the company's scale and operations.

What is Capricor Therapeutics, Inc. - Common Stock EBITDA?

Capricor Therapeutics, Inc. - Common Stock EBITDA is -36.23 M, and its EBITDA margin is -444.81 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Capricor Therapeutics, Inc. - Common Stock stock?

You can buy Capricor Therapeutics, Inc. - Common Stock (CAPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Capricor Therapeutics, Inc. - Common Stock stock?

Investing in Capricor Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CAPR chart and related analysis on metatrader.com as part of your research.

News